How do you utilize p53 NGS testing in your treatment planning for patients with CLL?   

What VAF burden would be considered significant prognostically or for treatment decisions?

Answer from: Medical Oncologist at Academic Institution
Medical Oncologist at Mary Lanning Healthcare Morrison Cancer Center/University of Nebraska Medical Center Adjunct Faculty
Thank you, Dr. @Byrd. Along the same topic, we wou...
Sign in or Register to read more